Foundational research has been the backbone of the institution and has led to its conception and formation. Learn more about this research and the ongoing discoveries in prestigious scientific journals below:
Related to high-throughput screening and discovery of new glial cell-targeted therapies:
A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity
2024
Nature Neuroscience
Benjamin L. L. Clayton, James D. Kristell, Kevin C. Allan, Erin F. Cohn, Molly Karl, Andrew D. Jerome, Eric Garrison, Yuka Maeno-Hikichi, Annalise M. Sturno, Alexis Kerr, H. Elizabeth Shick, Jesse A. Sepeda, Eric C. Freundt, Andrew R. Sas, Benjamin M. Segal, Robert H. Miller & Paul J. Tesar
Related to identifying mechanisms of glial cell dysfunction or vulnerability in disease:
Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis
2024
Cell Stem Cell
Pervasive environmental chemicals impair oligodendrocyte development
2024
Nature Neuroscience
Erin F. Cohn, Benjamin L. L. Clayton, Mayur Madhavan, Kristin A. Lee, Sara Yacoub, Yuriy Fedorov, Marissa A. Scavuzzo, Katie Paul Friedman, Timothy J. Shafer & Paul J. Tesar
Explore the research below centered on advanced cellular technologies for studying glial biology: